Why the study?
Does epidural anaesthesia and/or oxytocin infusion increase the frequency of uteroplacental insufficiency patterns in fetuses during labour?
Does epidural anaesthesia and/or oxytocin infusion increase the frequency of uteroplacental insufficiency patterns in fetuses during labour?
The combination of epidural anaesthesia and oxytocin stimulation during labour is associated with a higher frequency of fetal uteroplacental insufficiency patterns, which can be mitigated by maternal hydration and positioning.
Answers are grounded in this paper and cite their sources.
Combined epidural-oxytocin use was associated with more uteroplacental insufficiency patterns; hypothesis-generating and should not yet change practice.
Summary By direct continuous electronic monitoring 360 fetuses were observed for cardiac decelerations occurring late in the uterine contraction cycle during labour in four maternal treatment groups. Neither epidural anaesthesia nor oxytocin stimulation was used in 119 patients (Group A); oxytocin stimulation with other forms of anaesthesia was used in 41 patients (Group B); epidural anaesthesia without oxytocin in 135 patients (Group C); and the combination of epidural anaesthesia and oxytocin stimulation in 65 patients (Group D). The frequency of uteroplacental insufficiency (Hon, 1967), patterns in Group A was 16.8 per cent; Group B, 26.8 per cent; Group C, 24.4 per cent and Group D, 40 per cent. When a fall in maternal systolic blood pressure of greater than 20 mm. Hg occurred during epidural anaesthesia, 72 per cent of fetuses developed utero‐placental insufficiency patterns. When uterine hypertonus developed during oxytocin infusion 50 per cent of fetuses, including 5 of 7 fetuses subjected to tetanic contractions, developed late decelerations. Most fetuses who developed late decelerations had normal heart rate patterns before treatment. Control of oxytocin infusion and correction of hypotension by maternal hydration and avoidance of the supine position were usually accompanied by improvement in these ominous fetal heart rate patterns. There was no difference in neonatal outcome among the various treatment groups.
No takes yet. Share an insight, caveat, or question.
BarryS. Schifrin (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: